Anticancer drugs that induce cancer-associated cachectic syndromes (Q34734079)

4 August 2017

1 reference

title

Anticancer drugs that induce cancer-associated cachectic syndromes (English)

1 reference

4 August 2017

Akiko Tohgo

1 reference

4 August 2017

Eiji Kumazawa

1 reference

4 August 2017

Kouichi Akahane

1 reference

4 August 2017

Akihiro Asakawa

1 reference

4 August 2017

Akio Inui

1 reference

4 August 2017

publication date

1 February 2002

1 reference

Expert Review of Anticancer Therapy

4 August 2017

published in

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

121-129

1 reference

Scoring a bull's-eye against cancer genome targets

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

Cytokine production in five tumor cell lines with activity to induce cancer cachexia syndrome in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

In vivoEffect of Recombinant Human Leukemia Inhibitory Factor in Primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

Catabolism of adipose tissue by a tumour-produced lipid-mobilising factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

Novel sulfonamides as potential, systemically active antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

Tumor growth, weight loss and cytokines in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.121

21 January 2018

Identifiers

DOI

10.1586/14737140.2.1.121

1 reference

4 August 2017

1 reference